Exploring the Effects of Supervised Contrastive Learning on Alzheimer's Disease Classification With the F-18 AV45 PET Modality
ISEF · 2022 Computational Biology and Bioinformatics Third Award
Overview
Despite being one of the most common diseases in the world, Alzheimer’s disease is misdiagnosed at a high rate of 12% to 23% [1]. Current state-of-the-art machine learning models for Alzheimer’s disease classification typically use Supervised Cross-entropy loss. In this project, a novel implementation of Supervised Contrastive loss was developed and tested for performance on the classification of Alzheimer’s disease. Initial hyperparameter tuning was run on a standard Convolutional Neural Network (CNN) architecture using Cross-entropy loss, finding the optimal baseline parameters for the Supervised Cross-entropy model (SupCross). Secondary hyperparameter tuning was run on a Siamese CNN architecture using Supervised Contrastive loss, finding the optimal baseline parameters for the Supervised Contrastive model (SupCon). Seed testing was then run on both models and the best models were analyzed using Area Under Curve (AUC) on Receiver Operator Curves (ROC). The results support the hypothesis that SupCon models outperform SupCross models in performance and robustness for the classification task of Alzheimer’s disease using the F-18 AV45 modality. The optimal SupCon model achieved accuracies of 92% with an ROC AUC of 0.878, a 7% improvement over SupCross. The importance of this research is that it is the first paper to describe the potential for SupCon models to be used for classification in the setting of diagnostic medicine. With implications for a new state-of-the-art model for diagnostic medicine, the SupCon model can detect faint biomarkers existent in data undetectable by humans or other SupCross models.
Awards (2)
- Third Award of $1,000 $1,000
- Third Award of $1,000 $1,000
Competition history
- ISEF 2022
Resources
Related projects
ISEF · 2025
Advancing Alzheimer's Diagnosis With AH_Ad: A Classification Model Based on MRI Images
ISEF · 2020
Developing a Pre-Risk Assessment Incorporating Machine-Learning and Biomarkers to Diagnose Alzheimer's Disease
ISEF · 2022
A Novel Approach to Analyzing Alzheimer's Disease in MRI Scans Using a Convolutional Neural Network
ISEF · 2025
Promoting Equity: A Novel GAN-Based Framework for Improved MRI-Based Alzheimer's Diagnosis Utilizing Multiple Deep Learning Architectures
Closest projects by meaning, across every fair and year in the corpus.
Source: Regeneron International Science and Engineering Fair